Medpace Holdings logo

Medpace HoldingsNASDAQ: MEDP

Profile

Sector:

Healthcare

Country:

United States

IPO:

11 August 2016

Next earnings report:

12 February 2025

Last dividends:

N/A

Next dividends:

N/A
$10.14 B
-28%vs. 3y high
93%vs. sector
-39%vs. 3y high
52%vs. sector
-50%vs. 3y high
93%vs. sector
-34%vs. 3y high
61%vs. sector

Price

after hours | Wed, 20 Nov 2024 22:06:48 GMT
$326.09+$11.13(+3.53%)

Dividend

No data over the past 3 years
$533.32 M$535.11 M
$533.32 M$96.43 M

Analysts recommendations

Institutional Ownership

MEDP Latest News

MEDP Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ:MEDP) Investors with Significant Losses to Contact the Firm
accesswire.com20 November 2024 Sentiment: NEGATIVE

RADNOR, PA / ACCESSWIRE / November 20, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ:MEDP) ("Medpace"). On October 21, 2024, during after-market hours, Medpace reported its third quarter 2024 financial results and cut its revenue guidance for full-year 2024.

The Schall Law Firm Wants Shareholders To Join An Inquiry Into Medpace Holdings Inc For Violating Securities Laws
accesswire.com20 November 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / November 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

MEDP Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm
globenewswire.com18 November 2024 Sentiment: NEGATIVE

RADNOR, Pa., Nov. 18, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ: MEDP) (“Medpace”).

MEDP Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm
accesswire.com17 November 2024 Sentiment: NEGATIVE

RADNOR, PA / ACCESSWIRE / November 17, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ:MEDP) ("Medpace"). On October 21, 2024, during after-market hours, Medpace reported its third quarter 2024 financial results and cut its revenue guidance for full-year 2024.

The Schall Law Firm Encourages Stockholder Participation In An Inquiry Into Medpace Holdings Inc For Violating Securities Laws
accesswire.com17 November 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / November 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Medpace Holdings, Inc. Is Being Investigated By The Schall Law Firm For Fraud And Investors With Losses Are Invited To Help
accesswire.com16 November 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / November 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Reminder of Investigation of MEDP: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm
accesswire.com15 November 2024 Sentiment: NEGATIVE

RADNOR, PA / ACCESSWIRE / November 15, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP(www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ:MEDP) ("Medpace"). On October 21, 2024, during after-market hours, Medpace reported its third quarter 2024 financial results and cut its revenue guidance for full-year 2024.

Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Invited To Join The Schall Law Firm
accesswire.com15 November 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / November 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

MEDP Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm
prnewswire.com15 November 2024 Sentiment: NEGATIVE

RADNOR, Pa. , Nov. 15, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ: MEDP) ("Medpace").

Notice of Investigation of MEDP: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm
accesswire.com14 November 2024 Sentiment: NEGATIVE

RADNOR, PA / ACCESSWIRE / November 14, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP(www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ:MEDP) ("Medpace"). On October 21, 2024, during after-market hours, Medpace reported its third quarter 2024 financial results and cut its revenue guidance for full-year 2024.

What type of business is Medpace Holdings?

Medpace Holdings, Inc. specializes in conducting contract clinical research for companies in the biotechnology, pharmaceutical, and medical industries. It was founded in 1992. The headquarters is located in Cincinnati, Ohio (USA). Medpace Holdings, Inc. provides a wide range of services: monitoring clinical trials, laboratory analysis, electronic data capture, patient recruitment, and more. The company conducts scientific research on new drugs and medical devices in key therapeutic areas such as cardiology, hematology, oncology, neurology and psychiatry, vaccine development, antibiotics, etc. Clients of Medpace Holdings, Inc. include many leading global pharmaceutical, biotechnology companies, and medical device manufacturers.

What sector is Medpace Holdings in?

Medpace Holdings is in the Healthcare sector

What industry is Medpace Holdings in?

Medpace Holdings is in the Diagnostics & Research industry

What country is Medpace Holdings from?

Medpace Holdings is headquartered in United States

When did Medpace Holdings go public?

Medpace Holdings initial public offering (IPO) was on 11 August 2016

What is Medpace Holdings website?

https://www.medpace.com

Is Medpace Holdings in the S&P 500?

No, Medpace Holdings is not included in the S&P 500 index

Is Medpace Holdings in the NASDAQ 100?

No, Medpace Holdings is not included in the NASDAQ 100 index

Is Medpace Holdings in the Dow Jones?

No, Medpace Holdings is not included in the Dow Jones index

When was Medpace Holdings the previous earnings report?

No data

When does Medpace Holdings earnings report?

The next expected earnings date for Medpace Holdings is 12 February 2025